Additionally, SIGLEC9+ TAMs high infiltration served as an independent prognostic marker for overall survival, even after adjusting for age, tumor size, FIGO staging, histological type, and lymph node invasion (Table 3). This evidence concerns the gene SIGLEC9 and neoplasm.